ProKidney Corp. (BMV:PROK)

ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of MXN 7.72 billion. The enterprise value is 27.24 billion.

Market Cap	7.72B
Enterprise Value	27.24B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	135.98M
Shares Outstanding	n/a
Shares Change (YoY)	+102.08%
Shares Change (QoQ)	+1.36%
Owned by Insiders (%)	18.54%
Owned by Institutions (%)	16.52%
Float	87.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	777.11
PB Ratio	1.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.93
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.86

Financial Position

The company has a current ratio of 11.48, with a Debt / Equity ratio of 0.01.

Current Ratio	11.48
Quick Ratio	10.49
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-35,263.40

Financial Efficiency

Return on equity (ROE) is -40.51% and return on invested capital (ROIC) is -26.78%.

Return on Equity (ROE)	-40.51%
Return on Assets (ROA)	-25.30%
Return on Invested Capital (ROIC)	-26.78%
Return on Capital Employed (ROCE)	-51.27%
Revenue Per Employee	48,717
Profits Per Employee	-6.70M
Employee Count	204
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid 15.07 million in taxes.

Income Tax	15.07M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+46.19%
50-Day Moving Average	50.29
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.05
Average Volume (20 Days)	25,639

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.87

Income Statement

In the last 12 months, ProKidney had revenue of MXN 9.94 million and -1.37 billion in losses. Loss per share was -10.63.

Revenue	9.94M
Gross Profit	9.94M
Operating Income	-3.33B
Pretax Income	-3.09B
Net Income	-1.37B
EBITDA	-3.21B
EBIT	-3.33B
Loss Per Share	-10.63

Balance Sheet

The company has 5.56 billion in cash and 83.32 million in debt, giving a net cash position of 5.47 billion.

Cash & Cash Equivalents	5.56B
Total Debt	83.32M
Net Cash	5.47B
Net Cash Per Share	n/a
Equity (Book Value)	6.40B
Book Value Per Share	-141.70
Working Capital	5.59B

Cash Flow

In the last 12 months, operating cash flow was -2.16 billion and capital expenditures -606.48 million, giving a free cash flow of -2.76 billion.

Operating Cash Flow	-2.16B
Capital Expenditures	-606.48M
Free Cash Flow	-2.76B
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-33,456.74%
Pretax Margin	-31,053.89%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.08%
Shareholder Yield	-102.08%
Earnings Yield	-17.70%
FCF Yield	-35.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.62. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.62
Piotroski F-Score	n/a